ID   KS-EMPD-1
AC   CVCL_C4LP
DR   Wikidata; Q123032853
RX   PubMed=37432591;
CC   Population: Japanese.
CC   Doubling time: 31.2 +- 0.471 hours (PubMed=37432591).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Glu56Ter (c.166G>T); ClinVar=VCV001329425; Zygosity=Unspecified (PubMed=37432591).
CC   Omics: Deep exome analysis.
CC   Derived from site: In situ; Groin, skin; UBERON=UBERON_8410021.
ST   Source(s): PubMed=37432591
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 13
ST   D16S539: 9,11
ST   D21S11: 30,31
ST   D5S818: 10
ST   D7S820: 10,12
ST   TPOX: 8,12
ST   vWA: 14,18
DI   NCIt; C3302; Extramammary Paget disease
DI   ORDO; Orphanet_2800; Extramammary Paget disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   86Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
RX   PubMed=37432591; DOI=10.1007/s13577-023-00951-1;
RA   Ito T., Tanaka Y., Ichiki T., Kaku-Ito Y., Nakahara T.;
RT   "KS-EMPD-1: a novel cell line of primary extramammary Paget's
RT   disease.";
RL   Hum. Cell 36:1813-1829(2023).
//